Feline Immunodeficiency Virus Infection Phenotypically and Functionally Activates Immunosuppressive CD4+CD25+ T Regulatory Cells

Journal of Immunology

Volumn 172, Issue 8, 2004, Pages 4752-4761

  Vahlenkamp, Thomas W ^a,b   Tompkins, Mary B ^a   Tompkins, Wayne A F ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD4 ANTIGEN; CD86 ANTIGEN; CONCANAVALIN A; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; MITOGENIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAT; CONTROLLED STUDY; FELINE IMMUNODEFICIENCY VIRUS; FLOW CYTOMETRY; LYMPH NODE CELL; LYMPHOCYTE PROLIFERATION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIRUS INFECTION;

EID: 1642480365     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.8.4752     Document Type: Article

References (62)

1. Anderson, R. W., M. S. Ascher, and H. W. Sheppard. 1998. Direct HIV cytopathicity cannot account for CD4 decline in AIDS in the presence of homeostasis: a worst-case dynamic analysis. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 17:245.
2. Leng, Q., G. Borkow, Z. Weisman, M. Stein, A. Kalinkovich, and Z. Bentwich. 2001. Immune activation correlates better than HIV plasma viral load with CD4 T-cell decline during HIV infection. J. Acquir. Immune Defic. Syndr. 27:389.
3. Muro-Cacho, C., G. Pantaleo, and A. Fauci. 1995. Analysis of apoptosis in lymph nodes of HIV-infected persons: intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden. J. Immunol. 154:5555.
4. Hazenberg, M. D., S. A. Otto, B. H. van Benthem, M. T. Roos, R. A. Coutinho, J. M. Lange, D. Hamann, M. Prins, and F. Miedema. 2003. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 17:1881.
5. Sousa, A. E., J. Carneiro, M. Meier-Schellersheim, Z. Grossman, and R. M. Victorino. 2002. CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load. J. Immunol. 169:3400.
6. Miedema, F. 1992. Immunological abnormalities in the natural history of HIV infection: mechanisms and clinical relevance. Immunodefic. Rev. 3:173.
7. + T helper cell depletion occurs. J. Clin. Invest. 82:1908.
8. Meyaard, L., S. Otto, R. Jonker, M. Mijnster, R. Keet, and F. Miedema. 1992. Programmed cell death of T cells in HIV-1 infection. Science 257:217.
9. Gougeon, M. L., S. Garcia, J. Heeney, R. Tschopp, H. Lecoeur, D. Guetard, V. Rame, C. Dauguet, and L. Montagnier. 1993. Programmed cell death in AIDS-related HIV and SIV infections. AIDS Res. Hum. Retroviruses 9:553.
10. Finkel, T., G. Tudor-Williams, N. Banda, M. Cotton, T. Curiel, C. Monks, T. Baba, R. Ruprecht, and A. Kupfer. 1995. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nat. Med. 1:129.
11. Guiot, A., D. Rigal, and G. Chappuis. 1997. Spontaneous programmed cell death (PCD) process of lymphocytes of FIV-infected cats: cellular targets and modulation. Vet. Immunol. Immunopathol. 58:93.
12. Lawrence, C., J. Callanan, and O. Jarrett. 1992. Decreased mitogen responsiveness and elevated tumor necrosis factor production in cats shortly after feline immunodeficiency virus infection. Vet. Immunol. Immunopathol. 35:51.
13. + T cell apoptosis. J. Infect. Dis. 185:1077.
14. Trabattoni, D., M. Saresella, M. Biasin, A. Boasso, L. Piacentini, P. Ferrante, H. Dong, R. Maserati, G. M. Shearer, L. Chen, and M. Clerici. 2003. B7-H1 is up-regulated in HIV infection and is a novel surrogate marker of disease progression. Blood 101:2514.
15. Leng, Q., Z. Bentwich, E. Magen, A. Kalinkovich, and G. Borkow. 2002. CTLA-4 upregulation during HIV infection: association with anergy and possible target for therapeutic intervention. AIDS 16:519.
16. + T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10. J. Immunol. 166:3008.
17. + T cell subset that inhibits this autoimmune potential. J. Exp. Med. 177:627.
18. + Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals. Immunity 16:183.
19. Maloy, K. J., and F. Powrie. 2001. Regulatory T cells in the control of immune pathology. Nat. Immunol. 2:816.
20. + regulatory T cells control Leishmania major persistence and immunity. Nature 420:502.
21. + regulatory T cells induced by chronic retroviral infection. Proc. Natl. Acad. Sci. USA 98:9226.
22. + T cell-mediated pulmonary hyperinflammation driven by Pneumocystis carinii in immunodeficient mice. Eur. J. Immumol. 32:1282.
23. Singh, B., S. Read, C. Asseman, V. Malmstrom, C. Mottet, L. A. Stephens, R. Stepankova, H. Tlaskalova, and F. Powrie. 2001. Control of intestinal inflammation by regulatory T cells. Immunol. Rev. 182:190.
24. + immunoregulatory T cells that control autoimmune diabetes. Immunity 12:431.
25. - subpopulations. J. Immunol. 165:3105.
26. Sakaguchi, S., N. Sakaguchi, M. Asano, M. Itoh, and M. Toda. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155:1151.
27. + T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 193:1285.
28. + suppressor T cells. Immunol. Rev. 182:58.
29. + T cell responses. J. Exp. Med. 198:889.
30. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188:287.
31. + immunoregulatory T cells is antigen nonspecific. J. Immunol. 164:183.
32. + immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16:311.
33. + regulatory T cells is mediated by cell surface-bound transforming growth factor-β. J. Exp. Med. 194:629.
34. Alegre, M., F. Fallarino, P. Zhou, K. Frauwirth, J. Thistlethwaite, K. Newell, T. Gajewski, and J. Bluestone. 2001. Transplantation and the CD28/CTLA4/B7 pathway. Transplant. Proc. 33:209.
35. Folzenlogen, D., M. Hofer, D. Leung, J. Freed, and M. Newell, 1997. Analysis of CD80 and CD86 expression on peripheral blood B lymphocytes reveals increased expression of CD86 in lupus patients. Clin. Immunol. Immunopathol. 83:199.
36. Georgescu, L., R. Vakkalanka, K. Elkon, and M. Crow. 1997. Interleukin-10 promotes activation-induced cell death of SLE lymphocytes mediated by Fas ligand. J. Clin. Invest. 100:2622.
37. Ranheim, E., and T. Kipps. 1994. Elevated expression of CD80 (B7/BB1) and other accessory molecules on synovial fluid mononuclear cell subsets in rheumatoid arthritis. Arthritis Rheum. 37:1637.
38. Vervilghen, J., R. Lovis, M. De Boer, P. Linsley, G. Haines, A. Koch, and R. Pope. 1994. Expression of functional B7 and CTLA4 on rheumatoid synovial T cells. J. Immunol. 153:1378.
39. Wyss-Coray, T., D. Mauri-Hellweg, K. Baumann, F. Bettens, R. Grunow, and W. Pichler. 1993. The B7 adhesion molecule is expressed on activated human T cells: functional involvement in T-T cell interactions. Eur. J. Immunol. 23:2175.
40. + T cells. Eur. J. Immunol. 26:1700.
41. Kochli, C., T. Wendland, K. Frutig, R. Grunow, S. Merlin, and W. Pichler. 1999. CD80 and CD86 costimulatory molecules on circulating T cells of HIV infected individuals. Immunol. Lett. 65:197.
42. Caramalho, I., T. Lopes-Carvalho, D. Ostler, S. Zelenay, M. Haury, and J. Demengeot. 2003. Regulatory T cells selectively express Toll-like receptors and are activated by lipopolysaccharide. J. Exp. Med. 197:403.
43. + antiviral response that correlates with reduction of cell-associated virus. J. Infect. Dis. 177:18.
44. English, R. V., P. Nelson, C. M. Johnson, M. Nasisse, W. A. Tompkins, and M. B. Tompkins. 1994. Development of clinical disease in cats experimentally infected with feline immunodeficiency virus. J. Infect. Dis. 170:543.
45. Tompkins, M. B., G. K. Ogilvie, R. A. Franklin, K. W. Kelley, and W. A. Tompkins. 1987. Induction of IL-2 and lymphokine activated killer cells in the cat. Vet. Immunol. Immunopathol. 16:1.
46. Levy, J., J. Ritchey, J. Rottman, M. Davidson, Y. Liang, H. Jordan, W. Tompkins, and M. Tompkins. 1998. Elevated interleukin-10-to-interleukin-12 ratio in feline immunodeficiency virus-infected cats predicts loss of type 1 immunity to Toxoplasma gondii. J. Infect. Dis. 178:503.
47. Tompkins, M. B., D. H. Gebhard, H. R. Bingham, M. J. Hamilton, W. C. Davis, and W. A. F. Tompkins. 1990. Characterization of monoclonal antibodies to feline T lymphocytes and their use in the analysis of lymphocyte tissue distribution in the cat. Vet. Immunol. Immunopathol. 26:305.
48. Zola, H., L. Y. Koh, B. X. Mantzioris, and D. Rhodes. 1991. Patients with HIV infection have a reduced proportion of lymphocytes expressing the IL2 receptor p55 chain (TAC, CD25). Clin. Immunol. Immunopathol. 59:16.
49. Crabtree, G. R. 1989. Contingent genetic regulatory events in T lymphocyte activation. Science 243:355.
50. + T cells independent of cellular proliferation. Virology. In Press.
51. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192:303.
52. + regulatory cells that control intestinal inflammation. J. Exp. Med. 192:295.
53. + T cells with regulatory properties from human blood. J. Exp. Med. 193:1303.
54. high regulatory cells in human peripheral blood. J. Immunol. 167:1245.
55. +high regulatory T cell function. J. Immunol. 169:6210.
56. + suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2:389.
57. + regulatory T cells are essential components of the memory-protective immunity to Candida albicans. J. Immunol. 169:6298.
58. Davidson, M. G., J. Rottman, R. V. English, M. R. Lappin, and M. B. Tompkins. 1993. Feline immunodeficiency virus predisposes cats to acute generalized toxoplasmosis. Am. J. Pathol. 143:1486.
59. Yang, J., R. English, J. Ritchey, M. Davidson, T. Wasmoen, J. Levy, D. Gebhard, M. Tompkins, and W. Tompkins. 1996. Molecularly cloned feline immunodeficiency virus NCSU1 JSY3 induces immunodeficiency in specific-pathogen-free cats. J. Virol. 70:3011.
60. Clerici, M., N. Stocks, R. Zajac, R. Boswell, D. Lucey, C. Via, and G. Shearer. 1989. Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositve patients. J. Clin. Invest. 84:1892.
61. Torten, M., M. Franchini, J. E. Barlough, J. W. George, E. Mozes, H. Lutz, and N. C. Pedersen. 1991. Progressive immune dysfunction in cats experimentally infected with feline immunodeficiency virus. J. Virol. 65:2225.
62. Chou, C. S., O. Ramilo, and E. S. Vitetta. 1997. Highly purified CD25- resting T cells cannot be infected de novo with HIV-1. Proc. Natl. Acad. Sci. USA 94:1361.